Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link

Volume 12, Number 11—November 2006

Research

Staphylococcus aureus–associated Skin and Soft Tissue Infections in Ambulatory Care

Linda F. McCaig*Comments to Author , L. Clifford McDonald†, Sanjay Mandal†, and Daniel B. Jernigan†
Author affiliations: *Centers for Disease Control and Prevention, Hyattsville, Maryland, USA; †Centers for Disease Control and Prevention, Atlanta, Georgia, USA

Main Article

Table 4

Average annual antimicrobial prescribing rates at ambulatory care visits for selected skin and soft tissue infections, by therapeutic subclass, United States*

Therapeutic subclass† 1992–1994 2001–2003
No. prescriptions/10,000 visits/y 95% CI No. prescriptions/10,000 visits/y 95% CI
All visits 6,899.9 6431.5–7368.3 7,298.6 6870.7–7726.5
Cephalosporins 3,039.3 2,704.5–3374.1‡ 3,558.3 3,191.2–3,925.4‡
Penicillins 1,098.7 826.1–1371.3 1,404.2 1,141.0–1,667.4
Lincosamides and macrolides 1,377.7 1,081.9–1673.5 668.7 508.6–828.8
Quinolones § NA 646.3 472.8–819.8
Sulfonamides and related compounds, antibacterial agents, miscellaneous 580.8 390.9–770.7 542.2 361.9–722.5
Tetracyclines 134.2 73.6–194.8 258.3 146.8–369.8

*CI, confidence interval; NA, not applicable.
†Therapeutic subclass is based on the standard 4-digit drug classification used in the National Drug Code Directory, 1985 and 1995 editions, respectively.
‡1992–1994 95% CI overlaps with 2001–2003 95% CI, but p<0.05.
§Does not meet standard of reliability or precision.

*CI, confidence interval; NA, not applicable.
†Therapeutic subclass is based on the standard 4-digit drug classification used in the National Drug Code Directory, 1985 and 1995 editions, respectively.
‡1992–1994 95% CI overlaps with 2001–2003 95% CI, but p<0.05.
§Does not meet standard of reliability or precision.

Main Article

Page created: October 14, 2011
Page updated: October 14, 2011
Page reviewed: October 14, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external